6881. Efficacy and Safety of Tradipitant in Patients With Diabetic and Idiopathic Gastroparesis in a Randomized, Placebo-Controlled Trial.
作者: Jesse L Carlin.;V Rose Lieberman.;Arya Dahal.;Madison S Keefe.;Changfu Xiao.;Gunther Birznieks.;Thomas L Abell.;Anthony Lembo.;Henry P Parkman.;Mihael H Polymeropoulos.
来源: Gastroenterology. 2021年160卷1期76-87.e4页
Treatments are needed for gastroparesis; antagonists of tachykinin receptor 1 (TACR1, also called NK1R) can reduce symptoms of nausea and vomiting. We investigated the safety and efficacy of tradipitant, an antagonist of NK1R, in patients with idiopathic or diabetic gastroparesis.
6882. The Adherence to Infusible Biologic Therapies in Inflammatory Bowel Disease Patients during the COVID-19 Pandemic: Is It Really a Problem?
作者: Brigida Barberio.;Fabiana Zingone.;Lorenzo Bertani.;Edoardo Savarino.
来源: Gastroenterology. 2021年160卷5期1903-1904页 6887. Fecal Microbiota Transplantation Reduces Symptoms in Some Patients With Irritable Bowel Syndrome With Predominant Abdominal Bloating: Short- and Long-term Results From a Placebo-Controlled Randomized Trial.
作者: Tom Holvoet.;Marie Joossens.;Jorge F Vázquez-Castellanos.;Evelien Christiaens.;Lander Heyerick.;Jerina Boelens.;Bruno Verhasselt.;Hans van Vlierberghe.;Martine De Vos.;Jeroen Raes.;Danny De Looze.
来源: Gastroenterology. 2021年160卷1期145-157.e8页
Irritable bowel syndrome (IBS) is a functional gastrointestinal disorder associated with intestinal dysbiosis. Given the reported promising results of open-label fecal microbiota transplantation (FMT) therapy in patients with predominant abdominal bloating, we studied efficacy of this treatment in a randomized, placebo-controlled trial.
6888. Elastography for characterization of focal liver lesions: current evidence and future perspectives.
作者: Carolina Martelletti.;Angelo Armandi.;Gian Paolo Caviglia.;Giorgio M Saracco.;Rinaldo Pellicano.
来源: Minerva Gastroenterol (Torino). 2021年67卷2期196-208页
Focal liver lesions (FLLs) are a common finding during routine abdominal ultrasound (US). The differential diagnosis between diverse types of FLLs, especially between benign and malignant ones, is extremely important and can often be particularly challenging. Radiological techniques with contrast administration and/or liver biopsy are mostly necessary for establishing diagnosis, but they have several contraindications or complications. Due to limitations of these tools, there is urgent and still unmet need to develop a first line, non-invasive and simple method to diagnose FLLs. Elastography is an US-based imaging modality that provides information about the physical parameter corresponding to the tissue stiffness and can be considered a virtual biopsy. Several elastographic approaches have been developed, such as transient elastography, strain imaging and share wave imaging, which include point shear wave elastography and 2D shear wave elastography. These tools are already in use for evaluating liver fibrosis and in the assessment of focal lesions in other organs, like breast and thyroid gland. This review aims to assess the current evidence of different techniques based on elastography in the setting of FLLs, in order to evaluate accuracy, limitations and future perspectives. In particular, we focused on two contexts: the ability of discriminating between benign and malignant lesions, especially hepatocellular carcinoma and liver metastasis, and the surveillance after percutaneous therapy. This could have a high clinical impact making elastography crucial to identify the appropriate management of FLLs.
6889. Small bowel capsule endoscopy: where do we stand after 20 years of clinical use?
作者: Marco Pennazio.;Emanuele Rondonotti.;Rinaldo Pellicano.;Pablo Cortegoso Valdivia.
来源: Minerva Gastroenterol (Torino). 2021年67卷1期101-108页
Small bowel capsule endoscopy (SBCE) was introduced into clinical practice almost 20 years ago and, nowadays, it is an essential tool for the study of the small bowel. SBCE allows a radiation-free examination of the entire mucosal surface of the small bowel with high-quality images, limited invasivity and a good safety profile. Nevertheless, the main limitation of SBCE is the lack of any possible direct therapeutic intervention. Indications for SBCE have evolved throughout the years, from "old" ones such as suspected small bowel bleeding (still the main indication for SBCE) to newer ones such as refractory celiac disease, hereditary polyposis syndromes and Crohn's disease. Thus, nowadays SBCE has a key role in the diagnostic algorithms in many conditions. Furthermore, the introduction in the SBCE field of cutting-edge technologies, as artificial intelligence systems, is likely to shorten the reading time making SBCE even more effective and easy to perform. Preliminary data are extremely promising and solid evidence is being gathered by current studies.
6890. Ocular manifestations of inflammatory bowel diseases: an update for gastroenterologists.
作者: Fabio Castellano.;Giovanni Alessio.;Carmela Palmisano.
来源: Minerva Gastroenterol (Torino). 2021年67卷1期91-100页
Inflammatory bowel diseases (IBD), that includes ulcerative colitis and Crohn's disease, can affect not only the gastrointestinal tract but a wide spectrum of organs. The extra-intestinal manifestations (EIMs) are one of the most challenging aspect of IBD, playing a significant role for the lifetime care and the quality of life of patients. Ocular manifestations are the third most frequent EIMs, preceded by articular and dermatological ones. The aim of this narrative review is to describe the different types of ocular involvements, focusing on their clinical management. Uveitis and episcleritis are the most common ocular EIMs, differing for many aspects. Uveitis are unrelated with IBD activity and they even precede the onset of the intestinal disease, while episcleritis are common defined as a good mark of IBD activity. Pain is uncommon in most cases of episcleritis, while severe eye pain and photophobia are the most frequent onset of anterior uveitis. Less common but even more severe, are orbital pseudotumor or posterior segment involvement. Most of the ocular EIMs can be successfully treated with topic and oral steroids and the underlying therapy for IBD can reduce or cut out at all the recurrence of these manifestations. Symptoms are commonly not specific, in some cases being unnoticed for years leading to permanent ocular consequences. Cooperation between different specialists is crucial to avoid all the possible consequences of a non-treated EIMs, especially for ocular ones.
6892. Impact of E-cadherin and its transcription regulators on assessing epithelial-mesenchymal transition in chronic hepatitis C virus infection.
作者: Marwa Hassan.;Tarek Aboushousha.;Eman El-Ahwany.;Heba K Khalil.;Ahmed Y Montasser.;Hoda Abu-Taleb.;Mohamed D El-Talkawy.;Mona Zoheiry.
来源: Minerva Gastroenterol (Torino). 2021年67卷2期175-182页
The mechanisms of chronic hepatitis C virus (HCV)-induced liver fibrosis and hepatocarcinogenesis are still poorly recognized. Therefore, this study aimed to determine the effect of chronic HCV infection on the expression of the major regulators of epithelial-mesenchymal transition (EMT) including E-cadherin, Snail, Slug, and Twist2, in the Egyptian population. This will help to design more efficient strategies to treat HCV-associated cirrhosis and carcinoma.
6898. Irritable bowel syndrome and lactose intolerance: the importance of differential diagnosis. A monocentric study.
作者: Roberto Catanzaro.;Morena Sciuto.;Birbal Singh.;Surajit Pathak.;Francesco Marotta.
来源: Minerva Gastroenterol (Torino). 2021年67卷1期72-78页
Nowadays irritable bowel syndrome (IBS) and lactose intolerance (LI) are two very frequent diseases. IBS is a functional disorder, while LI is caused by the inability to digest lactose. LI is often incorrectly diagnosed as IBS. The aim of our study is to identify LI patients among IBS patients, so as to set up a correct therapy.
6899. Rheumatic manifestations in inflammatory bowel disease.
作者: Annacarla Finucci.;Maria Chiara Ditto.;Simone Parisi.;Richard Borrelli.;Marta Priora.;Cristina Realmuto.;Enrico Fusaro.
来源: Minerva Gastroenterol (Torino). 2021年67卷1期79-90页
Rheumatic manifestations are the most frequent extra-intestinal manifestations (EIMs) in inflammatory bowel disease (IBD) patients, and they are responsible for a relevant reduction of quality of life. IBD is associated with a variety of musculoskeletal manifestations such as arthritis and non-inflammatory pain as well as with metabolic diseases, such as osteoporosis. Different imaging techniques (primarily ultrasound, magnetic resonance imaging and X-rays) can help the clinician to correctly identify the nature of manifestations and to treat the patient accordingly. Nowadays, in the setting of IBD-related arthritides, different drugs are available and can be effective on both articular and intestinal involvement. Therefore, a multi-disciplinary approach provides an early diagnosis and a better clinical outcome that can only be given from the recognition and consideration of the different EIMs. As for rheumatic manifestations, namely IBD-related arthritis, an early intervention allows to control disease activity and to prevent structural damage.
|